Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent or Recurrent Cutaneous T-Cell Lymphoma”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Post-approval studies (Phase 4)Study completedNCT00050999
What this trial is testing

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Who this might be right for
Lymphoma, T-Cell, CutaneousMycosis FungoidesSezary Syndrome
Eisai Inc. 195
Large-scale testing (Phase 3)Study completedNCT01871727
What this trial is testing

A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

Who this might be right for
Persistent or Recurrent Cutaneous T-Cell Lymphoma
Eisai Inc. 112
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Study completedNCT00006345
What this trial is testing

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLymphoma
Ligand Pharmaceuticals
Not applicableStudy completedNCT00534118
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Roswell Park Cancer Institute 39